| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.YGYNO.2018.04.564 |
| P698 | PubMed publication ID | 29735278 |
| P50 | author | Mark F Munsell | Q90326364 |
| Karen H. Lu | Q117217757 | ||
| Andrea Bradford | Q51871522 | ||
| P2093 | author name string | Charlotte C Sun | |
| Laura L Holman | |||
| Gary B Chisholm | |||
| Jean Hurteau | |||
| Denise R Nebgen | |||
| Beth R Soletsky | |||
| P2860 | cites work | Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: Evidence for a causal relationship. | Q53337533 |
| The Sexual Activity Questionnaire: a measure of women's sexual functioning. | Q53627966 | ||
| The tubal fimbria is a preferred site for early adenocarcinoma in women with familial ovarian cancer syndrome. | Q53639283 | ||
| The genesis and evolution of high-grade serous ovarian cancer | Q55053523 | ||
| Society of Gynecologic Oncologists Education Committee Statement on Risk Assessment for Inherited Gynecologic Cancer Predispositions☆ | Q57908390 | ||
| A body image scale for use with cancer patients | Q61775185 | ||
| Patient satisfaction with health care decisions: the satisfaction with decision scale | Q71284789 | ||
| Attitudes about genetic testing for breast-ovarian cancer susceptibility | Q72348210 | ||
| Tubal ligation and risk of ovarian cancer in carriers of BRCA1 or BRCA2 mutations: a case-control study | Q73936350 | ||
| Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies | Q24531993 | ||
| Meta-analysis of BRCA1 and BRCA2 penetrance | Q24654786 | ||
| The Menopause Rating Scale (MRS) as outcome measure for hormone treatment? A validation study | Q24799993 | ||
| Society of Gynecologic Oncology recommendations for the prevention of ovarian cancer | Q27009306 | ||
| Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support | Q29547407 | ||
| Understanding the needs of women considering risk-reducing salpingo-oophorectomy | Q30419497 | ||
| A candidate precursor to serous carcinoma that originates in the distal fallopian tube. | Q33264156 | ||
| Impact of oophorectomy on cancer incidence and mortality in women with a BRCA1 or BRCA2 mutation | Q33633402 | ||
| The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory | Q33739695 | ||
| Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations | Q34129787 | ||
| Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality | Q34135443 | ||
| The molecular pathogenesis of hereditary ovarian carcinoma: alterations in the tubal epithelium of women with BRCA1 and BRCA2 mutations. | Q34288214 | ||
| The RAND-36 measure of health-related quality of life | Q34329583 | ||
| The distal fallopian tube: a new model for pelvic serous carcinogenesis. | Q34601152 | ||
| Microscopic and early-stage ovarian cancers in BRCA1/2 mutation carriers: building a model for early BRCA-associated tumorigenesis | Q34625221 | ||
| Risk-reducing salpingo-oophorectomy for the prevention of BRCA1- and BRCA2-associated breast and gynecologic cancer: a multicenter, prospective study | Q34749278 | ||
| Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer--shifting the paradigm | Q35140600 | ||
| Microenvironment and pathogenesis of epithelial ovarian cancer | Q35419057 | ||
| Hereditary cancer predisposition syndromes | Q36002146 | ||
| Primary fallopian tube malignancies in BRCA-positive women undergoing surgery for ovarian cancer risk reduction | Q36924865 | ||
| Clinical outcome of isolated serous tubal intraepithelial carcinomas (STIC) | Q37163464 | ||
| A Pathologist's Road Map to Benign, Precancerous, and Malignant Intraepithelial Proliferations in the Fallopian Tube | Q37781970 | ||
| NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2017. | Q39045746 | ||
| Anxiety/uncertainty reduction as a motivation for interest in prophylactic oophorectomy in women with a family history of ovarian cancer | Q39420650 | ||
| Opportunistic salpingectomy: uptake, risks, and complications of a regional initiative for ovarian cancer prevention. | Q42637128 | ||
| The Menopause Rating Scale (MRS): reliability of scores of menopausal complaints. | Q51958743 | ||
| Postpartum Permanent Sterilization: Could Bilateral Salpingectomy Replace Bilateral Tubal Ligation? | Q53090539 | ||
| Breast cancer risk following bilateral oophorectomy in BRCA1 and BRCA2 mutation carriers: an international case-control study. | Q53265333 | ||
| P433 | issue | 1 | |
| P921 | main subject | ovarian cancer | Q172341 |
| salpingectomy | Q3470206 | ||
| P304 | page(s) | 79-84 | |
| P577 | publication date | 2018-05-04 | |
| P1433 | published in | Gynecologic Oncology | Q5625182 |
| P1476 | title | Bilateral salpingectomy with delayed oophorectomy for ovarian cancer risk reduction: A pilot study in women with BRCA1/2 mutations | |
| P478 | volume | 150 |
| Q59813347 | An Unusual Adenomatoid Tumor of Fimbria with Pronounced Psammoma Bodies in a BRCA Positive Patient as a Pitfall for Carcinoma on Frozen Section |
| Q60931084 | Back to the Future? The Fallopian Tube, Precursor Escape and a Dualistic Model of High-Grade Serous Carcinogenesis |
| Q64063542 | Concerns and Expectations of Risk-Reducing Surgery in Women with Hereditary Breast and Ovarian Cancer Syndrome |
| Q92610003 | Epithelial ovarian cancer |
| Q90116183 | Is hormonal therapy after risk-reducing salpingo-oophorectomy associated with an increased risk of malignancy in pathogenic variant carriers? |
| Q92148409 | Ovarian Cancer Previvors: How to manage these patients? |
| Q89871616 | Perceptions of risk and reward in BRCA1 and BRCA2 mutation carriers choosing salpingectomy for ovarian cancer prevention |
| Q92509689 | Retrospective study of a 16 year cohort of BRCA1 and BRCA2 carriers presenting for RRSO: Prevalence of invasive and in-situ carcinoma, with follow-up |
| Q57688855 | Risk-reducing bilateral salpingo-oophorectomy in women with BRCA1 or BRCA2 mutations |
| Q89879980 | Screening and Prevention for High-Grade Serous Carcinoma of the Ovary Based on Carcinogenesis-Fallopian Tube- and Ovarian-Derived Tumors and Incessant Retrograde Bleeding |
| Q57139134 | Surgical prevention strategies in ovarian cancer |
Search more.